Organigram Global (OGI) Convertible Debt (2018)
Organigram Global (OGI) posted quarterly Convertible Debt of $95.9 million for Q3 2018.
Organigram Global (OGI) Convertible Debt (2018) Analysis & Trends
Organigram Global (OGI) has reported Convertible Debt for 1 consecutive years, with $95.9 million the latest figure, recorded in Q3 2018.
- Quarterly Convertible Debt changed N/A year-over-year to $95.9 million in Q3 2018, while the trailing twelve-month figure through Aug 2018 was $95.9 million (changed N/A YoY) and the FY2018 annual result came in at $95.9 million, changed N/A from the prior year.
- Convertible Debt steadied at $95.9 million in Q3 2018 per OGI's latest filing.
- Over the last five years, Convertible Debt for OGI reached as high as $95.9 million in Q3 2018 and fell as low as $95.9 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | 95.87 Mn |